Literature DB >> 10838474

Haematopoietic progenitors from umbilical cord blood.

A M Todaro1, C Pafumi, G Pernicone, S Munda, M R Pilastro, A Russo, M Farina, A Messina.   

Abstract

BACKGROUND/AIM: The aim of this study is to improve the obstetrician-based cord blood collection system and an efficient recovery of CD34+ haematopoietic progenitor stem cells.
METHODS: CD34+ cells were purified from total blood using a positive selection enrichment method, called Mini-Macs.
RESULTS: The final yield of CD34+ cells we obtained was 10(4) cells/ml, with a CD34+ purity of 99%.
CONCLUSION: Our results confirm that, by using this method, it is possible to get a significant stem cell number, thus improving transplanting both peripheral stem cells and umbilical cord ones. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10838474     DOI: 10.1159/000014438

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  4 in total

Review 1.  Transplantation of umbilical cord blood stem cells for treating spinal cord injury.

Authors:  Dong-Hyuk Park; Jeong-Hyun Lee; Cesario V Borlongan; Paul R Sanberg; Yong-Gu Chung; Tai-Hyoung Cho
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

2.  Multiple intravenous administrations of human umbilical cord blood cells benefit in a mouse model of ALS.

Authors:  Svitlana Garbuzova-Davis; Maria C O Rodrigues; Santhia Mirtyl; Shanna Turner; Shazia Mitha; Jasmine Sodhi; Subatha Suthakaran; David J Eve; Cyndy D Sanberg; Nicole Kuzmin-Nichols; Paul R Sanberg
Journal:  PLoS One       Date:  2012-02-03       Impact factor: 3.240

Review 3.  Mankind's first natural stem cell transplant.

Authors:  Jose N Tolosa; Dong-Hyuk Park; David J Eve; Stephen K Klasko; Cesario V Borlongan; Paul R Sanberg
Journal:  J Cell Mol Med       Date:  2010-02-05       Impact factor: 5.310

4.  Human umbilical cord blood treatment in a mouse model of ALS: optimization of cell dose.

Authors:  Svitlana Garbuzova-Davis; Cyndy Davis Sanberg; Nicole Kuzmin-Nichols; Alison E Willing; Carmelina Gemma; Paula C Bickford; Christina Miller; Robert Rossi; Paul R Sanberg
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.